What is the price target for BIG1 stock?
8 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 378.13% is expected in the next year compared to the current price of 0.64.
BIO-GATE AG (BIG1.DE) Forecast, Price Target & Analyst Ratings
FRA:BIG1 • DE000BGAG981
Current stock price
0.64 EUR
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIO-GATE AG (BIG1.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€3.06
Upside
+ 378.13%
From current price of €0.64 to mean target of €3.06, Based on 8 analyst forecasts
Low
€2.63
Median
€3.06
High
€3.57
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for BIG1.DE. The average price target is 3.06 EUR. This implies a price increase of 378.13% is expected in the next year compared to the current price of 0.64.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
BIG1.DE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BIG1.DE.
In the previous month the buy percentage consensus was at a similar level.
BIG1.DE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.99M -3.94% | 7.245M 20.96% | 7.053M -2.66% | 7.497M 6.30% | 8.109M 8.16% | 9.353M 15.34% | |
| EBITDA YoY % growth | -1.542M -351.26% | -1.323M 14.20% | -1.299M 1.84% | -963.9K 25.80% | -204K 78.84% | 321.3K 257.50% | |
| EBIT YoY % growth | -1.781M -233.10% | -1.59M 10.72% | -1.603M -0.80% | -1.255M 21.74% | -499.8K 60.16% | -25.5K 94.90% | |
| Operating Margin | -29.74% | -21.95% | -22.73% | -16.73% | -6.16% | -0.27% | |
| EPS YoY % growth | N/A | N/A -100.00% | N/A -37.50% | -0.12 30.30% | -0.05 60.87% | -0.01 88.89% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.35%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.77%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
30.30%
EBIT Next 5 Year
N/A
BIO-GATE AG / BIG1.DE Forecast FAQ
Can you provide the expected long term growth rate for BIO-GATE AG stock?
The expected long term growth rate for BIO-GATE AG (BIG1.DE) is 7.77%.